نتائج البحث - "NPH insulin"

11

Basal Insulin Analogs versus Neutral Protamine Hagedorn for Type 2 Diabetics

المؤلفون: Michal Fishel Bartal, Cornthwaite A. Joycelyn, Jerrie S. Refuerzo, Suneet P. Chauhan, Clara Ward, Baha M. Sibai, Han-Yang Chen, Sunbola S. Ashimi

المصدر: American Journal of Perinatology. 37:030-036

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a49537880b350e04c3751312b642e51Test
https://doi.org/10.1055/s-0039-1694733Test

12

Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: Post hoc cluster assignment analysis of over 12,000 study participants

المؤلفون: Wolfgang Landgraf, Gregory Bigot, Sibylle Hess, Olof Asplund, Leif Groop, Emma Ahlqvist, Annemari Käräjämäki, David R. Owens, Brian M. Frier, Geremia B. Bolli

المساهمون: Centre of Excellence in Complex Disease Genetics, HUS Abdominal Center, Institute for Molecular Medicine Finland, Leif Groop Research Group, Clinicum, University of Helsinki

المصدر: Diabetes Research and Clinical Practice. 190:110012

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044c48110a3e55ece388525f8230651fTest
https://doi.org/10.1016/j.diabres.2022.110012Test

13

For adults with type 1 diabetes mellitus, how do (ultra-)long-acting insulin analogs compare with neutral protamine Hagedorn (NPH) insulin?

المؤلفون: Christopher Bunt, Jane Burch, Sera Tort

المصدر: Cochrane Clinical Answers.

مصطلحات موضوعية: Type 1 diabetes, medicine.medical_specialty, biology, business.industry, NPH insulin, General Medicine, medicine.disease, Protamine, Endocrinology, Ultra long-acting insulin, Internal medicine, medicine, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::34e5621442566d5d42d4ae0d68126497Test
https://doi.org/10.1002/cca.3653Test

14

Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment

المؤلفون: Ulrik Pedersen-Bjergaard, Thomas Almdal, Katrine B. Hansen, Helga Holm Schultz, Tomas Møller Christensen, Peter Lommer Kristensen, Frederik Persson, Carina Kirstine Klarskov, Ole Snorgaard

المصدر: BMC Endocrine Disorders
BMC Endocrine Disorders, Vol 20, Iss 1, Pp 1-11 (2020)
Klarskov, C K, Holm Schultz, H, Persson, F, Møller Christensen, T, Almdal, T P, Snorgaard, O, Bagge Hansen, K, Pedersen-Bjergaard, U & Lommer Kristensen, P 2020, ' Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs)-a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatment ', BMC Endocrine Disorders, vol. 20, no. 1, 86 . https://doi.org/10.1186/s12902-020-00561-0Test

مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Insulin, Isophane, NPH insulin, Equivalence Trials as Topic, Glycemic Control, lcsh:Diseases of the endocrine glands. Clinical endocrinology, law.invention, Study Protocol, Randomized controlled trial, Glucosides, law, Diabetes mellitus, Internal medicine, Multicenter trial, Clinical endpoint, Empagliflozin, medicine, Humans, Hypoglycemic Agents, Multicenter Studies as Topic, Patient Reported Outcome Measures, Benzhydryl Compounds, Glucocorticoids, Sodium-Glucose Transporter 2 Inhibitors, Monitoring, Physiologic, Randomized Controlled Trials as Topic, NPH-insulin, lcsh:RC648-665, business.industry, CGM, Insulin, Blood Glucose Self-Monitoring, Diabetes, General Medicine, medicine.disease, Hypoglycemia, Treatment Outcome, Diabetes Mellitus, Type 2, business, SGLT2-i, Steroid diabetes, RCT